Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | TP53 | P04637 | 3/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18116566 | 0.88 | TSHR (0.42) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL25644164 | 0.83 | ALDH1A1 (0.34) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL28638915 | 0.81 | TSHR (0.38) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL42549 | 0.79 | TSHR (0.52) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL21816726 | 0.79 | TSHR (0.38) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL5269389 | 0.76 | TSHR (0.59) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL21517646 | 0.76 | APEX1 (0.37) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL19117419 | 0.76 | ALDH1A1 (0.50) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL21271474 | 0.75 | GSTP1 (0.41) | ALDH1A1 | |
| SCHEMBL8747671 | 0.75 | ALDH1A1 (0.53) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260112-A | Sexek derivative and preparation method and application thereof | 佳化化学科技发展（上海）有限公司 | 2022-11-01 | — | — | CN | disclosed |
| US-11424482-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-08-23 | — | — | US | disclosed |
| US-11296357-B2 | Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-04-05 | — | — | US | disclosed |
| CN-109562989-B | Optical fiber and method for manufacturing optical fiber | 住友电气工业株式会社 | 2021-10-26 | — | — | CN | disclosed |
| US-20210020991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
| US-10615455-B2 | Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-04-07 | — | — | US | disclosed |
| US-20200036041-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20190334208-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-10-31 | — | — | US | disclosed |
| US-10451796-B2 | Optical fiber and method for producing optical fiber | SUMITOMO ELECTRIC INDUSTRIES, LTD. (JP) | 2019-10-22 | — | — | US | disclosed |
| US-10424812-B2 | Non-aqueous electrolytic solution and non-aqueous electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-09-24 | — | — | US | disclosed |
| US-6787197-B1 | Method for producing scratch resistant, weatherproof coatings | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-07 | — | — | US | disclosed |
| US-20040018367-A1 | Method for producing a curable aqueous polymer dispersion | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-29 | — | — | US | disclosed |
| US-6668122-B2 | Comprising quartz glass fiber, primary coating and secondary coating formed by curing resin composition comprising polyurethane (meth)acrylate oligomer; minimized transmission loss | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-12-23 | — | — | US | disclosed |
| US-6602929-B1 | Reaction product of a polyether having a (meth)acryloyl group and a hydroxyl group at opposite ends with a diisocyante; Upon curing, it forms a coating having a minimized water absorption on the optical fiber | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2003-08-05 | — | — | US | disclosed |
| US-20020183411-A1 | Electron-beam curable composition comprising polyurethane and thiazole, imidazole, and/or thiourea compound; minimal gelling and tensile strength; uniformity | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-12-05 | — | — | US | disclosed |
| US-20020159737-A1 | Coated optical fiber | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-10-31 | — | — | US | disclosed |
| EP-1231190-A1 | Coated optical fiber | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-08-14 | — | — | EP | disclosed |
| US-6198867-B1 | POLYSILOXANE ENDCAPPED WITH (METH)ACRYL GROUP, AND CONTAINING AROMATIC HYDROCARBON GROUPS ATTACHED TO SILICON ATOMS, AN UNSATURATED COMPOUND, AND A PHOTOPOLYMERIZATION CATALYST; LOW VISCOSITY, CURES TO A LOW YOUNG'S MODULUS COATING | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| EP-1046619-A2 | Coated optical fibres and their manufacture | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-10-25 | — | — | EP | disclosed |
| EP-0970978-A1 | Radiation-curable liquid resin composition suitable for coating optical fibers and optical fiber coated therewith | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210020991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | SLC9B2, SLC9A1, SLC9A2 | TSHR 4689/4885ALDH1A1 3675/4885TP53 4229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.